Anti T-lymphocyte Immunoglobulin With Post Transplant Cyclophosphamide to Prevent GVHD Post Allogeneic Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Graft Versus Host Disease
Related studies linked through entity extraction aliases.
Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRIC
- Status
- TERMINATED
- Phase
- PHASE2
Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver Transplantation
- Status
- UNKNOWN
- Phase
- NA
High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant
- Status
- TERMINATED
- Phase
- NA
A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Efficacy and Safety of Nilotinib in Patients With a Chronic Disease of the Graft Against the Host
- Status
- COMPLETED
- Phase
- PHASE2
Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients
- Status
- TERMINATED
- Phase
- PHASE2
Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease
- Status
- COMPLETED
- Phase
- PHASE1
T Lymphocytes (LT) Expressing iCASP9 and ΔCD19 in Allogeneic Haematopoietic Transplantation.
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Early Detection of Mucosal Abnormalities in Graft-versus-host Disease
- Status
- COMPLETED
- Phase
- NA
Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling Donor
- Status
- COMPLETED
- Phase
- PHASE4
Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention
- Status
- COMPLETED
- Phase
- PHASE2
Donor Regulatory T Cells in Treating Patients With Visceral Acute Graft-versus-Host Disease After Stem Cell Transplant
- Status
- WITHDRAWN
- Phase
- PHASE1
Transdermal Patch to Monitor Inflammatory Biomarkers of GVHD
- Status
- COMPLETED
- Phase
- NA
Irradiated Blood Versus Non Irradiated Blood Transfusions in Craniosynostosis Repair
- Status
- COMPLETED
- Phase
- NA
Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT
- Status
- COMPLETED
- Phase
- N/A